Study on the conditions of the metaiodobenzylguanidine (MIBG) labelled with 131I

被引：0
|
作者：
China Institute of Atomic Energy, P.O. Box 275 , Beijing 102413, China [1 ]
机构：
来源：
J. Radioanal. Nucl. Chem. | / 1卷 / 37-41期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Both rapid and simple method of 131I labelled MIBG was described. The labelling efficiency is more than 97% using Cu(Ac)2 as a catalyst, acetic acid, alcohol system as a medium of exchange reactions under the certain labelling conditions. The stability of the labelled 131I-MIBG at the room temperature met the demand of the clinical application. Copyright © 1996 Akadémiai Kiadó. All rights reserved.
引用
收藏
相关论文
共 50 条
  • [41] EXPERIENCE WITH I-131 METAIODOBENZYLGUANIDINE (METAIODOBENZYLGUANIDINE) - A RETROSPECTIVE STUDY
    CHAN, R
    WARSHAWSKI, RS
    SCOTT, J
    ARNOLD, RW
    JOURNAL OF THE CANADIAN ASSOCIATION OF RADIOLOGISTS-JOURNAL DE L ASSOCIATION CANADIENNE DES RADIOLOGISTES, 1987, 38 (01): : 35 - 39
  • [42] EXCRETION OF VOLATILE 131I FROM RATS FOLLOWING ADMINISTRATION OF NA131I OR MIBG-131I
    Li, Chunsheng
    Sadi, Baki
    Wyatt, Heather
    Bugden, Michelle
    Wilkinson, Diana
    Cornett, Jack
    Kramer, Gary H.
    RADIATION PROTECTION DOSIMETRY, 2012, 148 (02) : 143 - 148
  • [43] Effectiveness of Short-term Repeated 131I metaiodobenzylguanidine (MIBG) Radiotherapy for Preventing Disease Progression in Patients with Malignant Neuroendocrine Tumors
    Yoshinaga, Keiichiro
    Okamoto, Shozo
    Shiga, Tohru
    Shinohara, Nobuo
    Abe, Takashige
    Uchiyama, Yuko
    Tamaki, Nagara
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [44] Malignant pheochromocytomas and paragangliomas -: A phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG)
    Fitzgerald, Paul A.
    Goldsby, Robert E.
    Huberty, John P.
    Price, David C.
    Hawkins, Randall A.
    Veatch, Janet J.
    Dela Cruz, Filemon
    Jahan, Thierry M.
    Linker, Charles A.
    Damon, Lloyd
    Matthay, Katherine K.
    PHEOCHROMOCYTOMA, 2006, 1073 : 465 - 490
  • [45] THE PROGRESSIVE AND DIFFUSE NATURE OF NEURO-BLASTOMA - TREATMENT WITH I-131 METAIODOBENZYLGUANIDINE (I-131 MIBG)
    SHEN, SW
    SISSON, JC
    HUTCHINSON, R
    SHAPIRO, B
    SHULKIN, B
    GEATTI, O
    MALLETT, S
    EYRE, P
    MANGNER, T
    BEIERWALTES, WH
    JOURNAL OF NUCLEAR MEDICINE, 1985, 26 (05) : P75 - P76
  • [46] 131I MIBG therapy in neuroblastoma:: Mechanisms, rationale, and current status
    Tepmongkol, S
    Heyman, S
    MEDICAL AND PEDIATRIC ONCOLOGY, 1999, 32 (06): : 427 - 431
  • [47] Diagnosis of pheochromocytoma using [123I]-compared with [131I]-metaiodobenzylguanidine scintigraphy
    Furuta, N
    Kiyota, H
    Yoshigoe, F
    Hasegawa, N
    Ohishi, Y
    INTERNATIONAL JOURNAL OF UROLOGY, 1999, 6 (03) : 119 - 124
  • [48] Comparison of [123I]MIBG and [131I]MIBG for imaging of neuroblastoma and other neural crest tumors
    Liu, B.
    Zhuang, H.
    Servaes, S.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 57 (01): : 21 - 28
  • [49] The role of 131I-metaiodobenzylguanidine (MIBG) therapy in unresectable and compromising localised neuroblastoma
    Reineke A. Schoot
    Gitta Bleeker
    Huib N. Caron
    Berthe L. van Eck
    Hugo A. Heij
    Jan de Kraker
    Godelieve A. Tytgat
    European Journal of Nuclear Medicine and Molecular Imaging, 2013, 40 : 1516 - 1522
  • [50] The role of 131I-metaiodobenzylguanidine (MIBG) therapy in unresectable and compromising localised neuroblastoma
    Schoot, Reineke A.
    Bleeker, Gitta
    Caron, Huib N.
    van Eck, Berthe L.
    Heij, Hugo A.
    de Kraker, Jan
    Tytgat, Godelieve A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (10) : 1516 - 1522
12345